Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2002

PHARMANIAGA BERHAD

Quarterly report for the financial period ended30/09/2002
Quarter3
Financial Year End31/12/2002
The figureshave not been audited

Attachments

long_0209_f.doc
156 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2002


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2002 
30/09/2001 
30/09/2002 
30/09/2001 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
157,354
141,277
455,450
403,980
2Profit/(loss) before tax
19,525
13,040
49,883
36,690
3Profit/(loss)
after tax and minority
interest
12,073
7,639
30,562
22,653
4Net profit/(loss) for
the period
12,073
7,639
30,562
22,653
5Basic earnings/(loss) per share (sen)
24.10
15.30
61.10
45.30
6Dividend per share (sen)
2.50

2.50




AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net tangible assets per share (RM)

3.4500
3.2100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced22 Nov 2002  
CategoryFinancial Results
Reference NoCR-021122-60370